Experts praise FDA’s cautious approach to psychedelic medicine
As the Food and Drug Administration inches toward possible approval of psilocybin, a psychedelic medicine, experts are praising its methodical approach.
To access this content, you must purchase a Premium membership, or log in if you are a member.